Greenwich LifeSciences, Inc. (GLSI)
NASDAQ·Healthcare·Biotechnology
$15.42
+2.39%
Mkt Cap $287.25M
Analyst Ratings
No recent rating data.
Price Target (1 analysts)
$50.00
Range $50.00 – $50.00
Implied Upside
+224.3%
Consensus $50.00 vs current $15.42